For the Inventor, By the Inventor

Enter assignee name

Foster City, CA, United States of America

Ym Biosciences Australia Pty Ltd.

USPTO Granted Patents = 18

CIPO Patents = 34

EPO Patents = 12

Forward Citations = 155

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Christopher John Burns (16 out of 26 patents)

Andrew Frederick Wilks (10 out of 34 patents)

John Thomas Feutrill (6 out of 12 patents)

4. Michael Francis Harte (6 out of 7 patents)

5. Harrison Sikanyika (5 out of 5 patents)

6. Emmanuelle Fantino (5 out of 6 patents)

7. Marcel Robert Kling (5 out of 5 patents)

8. Jun Zeng (4 out of 7 patents)

9. David Gerard Bourke (4 out of 5 patents)

10. Anthony Nicholas Cuzzupe (4 out of 5 patents)

11. Xianyong Bu (4 out of 9 patents)

12. Tracy Leah Nero (4 out of 5 patents)

13. Andrew Donohue (2 out of 3 patents)

14. Thao Lien Thi Nguyen (2 out of 3 patents)

15. Lawrence S Zisman (1 out of 9 patents)

18 patents: Sort by Forward Citations

1. 9732046 - Substituted 1,2,4-triazines as tubulin inhibitors (2017-08-15),

2. 9499560 - N-containing heterocyclic compounds (2016-11-22),

3. 9233934 - Phenyl amino pyrimidine compounds and uses thereof (2016-01-12),

4. 9139560 - Substituted pyrazines as tubulin inhibitors (2015-09-22),

5. 9040549 - Thiopyrimidine-based compounds and uses thereof (2015-05-26),

6. 8809359 - Phenyl amino pyrimidine bicyclic compounds and uses thereof (2014-08-19),

7. 8765755 - N-containing heterocyclic compounds (2014-07-01),

8. 8486941 - Phenyl amino pyrimidine compounds and uses thereof (2013-07-16),

9. 8461161 - Substituted pyrazines as inhibitors of kinase activity (2013-06-11),

10. 8410173 - Inhibition of JAK2 as a treatment of pulmonary arterial hypertension (2013-04-02),

11. 8394806 - 2-phenyl pyrazines as tubulin inhibitors (2013-03-12),

12. 8354408 - N-containing heterocyclic compounds (2013-01-15),

13. 8329737 - Benzimidazoles as selective kinase inhibitors (2012-12-11),

14. 8084456 - Pyrazine-based tubulin inhibitors (2011-12-27),

15. 8030336 - Nicotinamide-based kinase inhibitors (2011-10-04),

YM BioSciences Australia Pty Ltd. is a biotechnology company specializing in the development of innovative cancer therapeutics. With a focus on identifying and advancing novel drug candidates, YM BioSciences aims to address unmet medical needs and improve patient outcomes. Through extensive research and collaboration, the company strives to bring transformative treatments to market that have the potential to revolutionize cancer care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

18 Patents

#26 in Foster City, CA

#4,144 in California

#17,372 in US

#33,129 in the World

Foster City, CA, United States of America

Ym Biosciences Australia Pty Ltd.

Forward Citations = 155

31 inventors:

Christopher John Burns (16 out of 26 patents)

Andrew Frederick Wilks (10 out of 34 patents)

John Thomas Feutrill (6 out of 12 patents)

4. Michael Francis Harte (6 out of 7 patents)

5. Harrison Sikanyika (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…